BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patterson AD, Maurhofer O, Beyoglu D, Lanz C, Krausz KW, Pabst T, Gonzalez FJ, Dufour JF, Idle JR. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res. 2011;71:6590-6600. [PMID: 21900402 DOI: 10.1158/0008-5472.can-11-0885] [Cited by in Crossref: 182] [Cited by in F6Publishing: 96] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Beger RD. A review of applications of metabolomics in cancer. Metabolites 2013;3:552-74. [PMID: 24958139 DOI: 10.3390/metabo3030552] [Cited by in Crossref: 136] [Cited by in F6Publishing: 117] [Article Influence: 15.1] [Reference Citation Analysis]
2 Passos-Castilho AM, Carvalho VM, Cardozo KH, Kikuchi L, Chagas AL, Gomes-Gouvêa MS, Malta F, de Seixas-Santos Nastri AC, Pinho JR, Carrilho FJ, Granato CF. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry. BMC Cancer 2015;15:985. [PMID: 26680993 DOI: 10.1186/s12885-015-1995-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
3 Kimhofer T, Fye H, Taylor-Robinson S, Thursz M, Holmes E. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br J Cancer. 2015;112:1141-1156. [PMID: 25826224 DOI: 10.1038/bjc.2015.38] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 10.4] [Reference Citation Analysis]
4 Chauhan N, Dhasmana A, Jaggi M, Chauhan SC, Yallapu MM. miR-205: A Potential Biomedicine for Cancer Therapy. Cells 2020;9:E1957. [PMID: 32854238 DOI: 10.3390/cells9091957] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ressom HW, Xiao JF, Tuli L, Varghese RS, Zhou B, Tsai TH, Ranjbar MR, Zhao Y, Wang J, Di Poto C. Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. Anal Chim Acta. 2012;743:90-100. [PMID: 22882828 DOI: 10.1016/j.aca.2012.07.013] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 10.0] [Reference Citation Analysis]
6 Kirchberger-Tolstik T, Ryabchykov O, Bocklitz T, Dirsch O, Settmacher U, Popp J, Stallmach A. Nondestructive molecular imaging by Raman spectroscopy vs. marker detection by MALDI IMS for an early diagnosis of HCC. Analyst 2021;146:1239-52. [PMID: 33313629 DOI: 10.1039/d0an01555e] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Virseda-Berdices A, Rojo D, Martínez I, Berenguer J, González-García J, Brochado-Kith O, Fernández-Rodríguez A, Díez C, Hontañon V, Pérez-Latorre L, Micán R, Barbas C, Resino S, Jiménez-Sousa MA; ESCORIAL Study Group. Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients. Biomed Pharmacother 2022;147:112623. [PMID: 35032770 DOI: 10.1016/j.biopha.2022.112623] [Reference Citation Analysis]
8 Zhang A, Sun H, Yan G, Wang P, Wang X. Metabolomics for Biomarker Discovery: Moving to the Clinic. Biomed Res Int 2015;2015:354671. [PMID: 26090402 DOI: 10.1155/2015/354671] [Cited by in Crossref: 44] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
9 Mei R, Chen D, Zhong D, Li G, Lin S, Zhang G, Chen K, Yu X. Metabolic Profiling Analysis of the Effect and Mechanism of Gushiling Capsule in Rabbits With Glucocorticoid-Induced Osteonecrosis of the Femoral Head. Front Pharmacol 2022;13:845856. [DOI: 10.3389/fphar.2022.845856] [Reference Citation Analysis]
10 Khalil A, Elsheashaey A, Abdelsameea E, Obada M, Mohamed Bayomy FF, El-said H. Role of bile acids in the prediction of hepatocellular carcinoma in HCV-induced liver cirrhosis. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00142-3] [Reference Citation Analysis]
11 Feng N, Yu F, Yu F, Feng Y, Zhu X, Xie Z, Zhai Y. Metabolomic biomarkers for hepatocellular carcinoma: A systematic review. Medicine (Baltimore) 2022;101:e28510. [PMID: 35060504 DOI: 10.1097/MD.0000000000028510] [Reference Citation Analysis]
12 Li Z, Guan M, Lin Y, Cui X, Zhang Y, Zhao Z, Zhu J. Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics. Int J Mol Sci 2017;18:E2550. [PMID: 29182572 DOI: 10.3390/ijms18122550] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
13 Fages A, Duarte-Salles T, Stepien M, Ferrari P, Fedirko V, Pontoizeau C, Trichopoulou A, Aleksandrova K, Tjønneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Severi G, Kaaks R, Kuhn T, Floegel A, Boeing H, Lagiou P, Bamia C, Trichopoulos D, Palli D, Pala V, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Agudo A, Molina-Montes E, Huerta JM, Ardanaz E, Dorronsoro M, Sjöberg K, Ohlsson B, Khaw KT, Wareham N, Travis RC, Schmidt JA, Cross A, Gunter M, Riboli E, Scalbert A, Romieu I, Elena-Herrmann B, Jenab M. Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC Med 2015;13:242. [PMID: 26399231 DOI: 10.1186/s12916-015-0462-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 7.6] [Reference Citation Analysis]
14 Bowers J, Hughes E, Skill N, Maluccio M, Raftery D. Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS. J Chromatogr B Analyt Technol Biomed Life Sci 2014;966:154-62. [PMID: 24666728 DOI: 10.1016/j.jchromb.2014.02.043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
15 Zhang T, Zhao Q, Xiao X, Yang R, Hu D, Zhu X, Gonzalez FJ, Li F. Modulation of Lipid Metabolism by Celastrol. J Proteome Res 2019;18:1133-44. [PMID: 30706713 DOI: 10.1021/acs.jproteome.8b00797] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
16 Shariff MI, Tognarelli JM, Lewis MR, Want EJ, Mohamed Fel Z, Ladep NG, Crossey MM, Khan SA, Jalan R, Holmes E, Taylor-Robinson SD. Plasma Lipid Profiling in a Rat Model of Hepatocellular Carcinoma: Potential Modulation Through Quinolone Administration. J Clin Exp Hepatol 2015;5:286-94. [PMID: 26900269 DOI: 10.1016/j.jceh.2015.07.205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
17 Huang G, Wang L, Li J, Hou R, Wang M, Wang Z, Qu Q, Zhou W, Nie Y, Hu Y, Ma Y, Yan L, Wei H, Wei F. Seasonal shift of the gut microbiome synchronizes host peripheral circadian rhythm for physiological adaptation to a low-fat diet in the giant panda. Cell Rep 2022;38:110203. [PMID: 35045306 DOI: 10.1016/j.celrep.2021.110203] [Reference Citation Analysis]
18 Steven LCT, Yi GX. Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine. Chin J Integr Med 2021;27:788-93. [PMID: 32720117 DOI: 10.1007/s11655-020-3217-1] [Reference Citation Analysis]
19 Jhuang HJ, Hsu WH, Lin KT, Hsu SL, Wang FS, Chou CK, Lee KH, Tsou AP, Lai JM, Yeh SF, Huang CY. Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1α-dependent pathway. Oncotarget 2015;6:7788-803. [PMID: 25762623 DOI: 10.18632/oncotarget.3050] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
20 Xiao JF, Varghese RS, Zhou B, Nezami Ranjbar MR, Zhao Y, Tsai TH, Di Poto C, Wang J, Goerlitz D, Luo Y, Cheema AK, Sarhan N, Soliman H, Tadesse MG, Ziada DH, Ressom HW. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort. J Proteome Res. 2012;11:5914-5923. [PMID: 23078175 DOI: 10.1021/pr300673x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 77] [Article Influence: 8.4] [Reference Citation Analysis]
21 Shu X, Zheng W, Yu D, Li HL, Lan Q, Yang G, Cai H, Ma X, Rothman N, Gao YT, Jia W, Xiang YB, Shu XO. Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk. Int J Cancer. 2018;143:2161-2167. [PMID: 29717485 DOI: 10.1002/ijc.31574] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
22 Nishiumi S, Suzuki M, Kobayashi T, Matsubara A, Azuma T, Yoshida M. Metabolomics for biomarker discovery in gastroenterological cancer. Metabolites 2014;4:547-71. [PMID: 25003943 DOI: 10.3390/metabo4030547] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
23 Vermeersch KA, Styczynski MP. Applications of metabolomics in cancer research. J Carcinog. 2013;12:9. [PMID: 23858297 DOI: 10.4103/1477-3163.113622] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 6.7] [Reference Citation Analysis]
24 Khan V, Putluri N, Sreekumar A, Mindikoglu AL. Current Applications of Metabolomics in Cirrhosis. Metabolites 2018;8:E67. [PMID: 30360420 DOI: 10.3390/metabo8040067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Knuplez E, Marsche G. An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System. Int J Mol Sci 2020;21:E4501. [PMID: 32599910 DOI: 10.3390/ijms21124501] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
26 Kumar N, Hoque MA, Shahjaman M, Islam SM, Mollah MN. Metabolomic Biomarker Identification in Presence of Outliers and Missing Values. Biomed Res Int 2017;2017:2437608. [PMID: 28293630 DOI: 10.1155/2017/2437608] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
27 Xu J, Chen Y, Zhang R, He J, Song Y, Wang J, Wang H, Wang L, Zhan Q, Abliz Z. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging. Sci Rep 2016;6:35010. [PMID: 27725730 DOI: 10.1038/srep35010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
28 Beyoğlu D, Idle JR. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites 2020;10:E50. [PMID: 32012846 DOI: 10.3390/metabo10020050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
29 Qi Y, Jiang C, Cheng J, Krausz KW, Li T, Ferrell JM, Gonzalez FJ, Chiang JY. Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice. Biochim Biophys Acta. 2015;1851:19-29. [PMID: 24796972 DOI: 10.1016/j.bbalip.2014.04.008] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 12.6] [Reference Citation Analysis]
30 Baniasadi H, Gowda GA, Gu H, Zeng A, Zhuang S, Skill N, Maluccio M, Raftery D. Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MS. Electrophoresis 2013;34:2910-7. [PMID: 23856972 DOI: 10.1002/elps.201300029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
31 Qi Y, Jiang C, Tanaka N, Krausz KW, Brocker CN, Fang ZZ, Bredell BX, Shah YM, Gonzalez FJ. PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate. Am J Physiol Gastrointest Liver Physiol 2014;307:G564-73. [PMID: 25035112 DOI: 10.1152/ajpgi.00153.2014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
32 Jin C, Yuan P. Implications of lipid droplets in lung cancer: Associations with drug resistance. Oncol Lett 2020;20:2091-104. [PMID: 32782526 DOI: 10.3892/ol.2020.11769] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
33 Gusenleitner D, Auerbach SS, Melia T, Gómez HF, Sherr DH, Monti S. Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action. PLoS One 2014;9:e102579. [PMID: 25058030 DOI: 10.1371/journal.pone.0102579] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
34 Huang Q, Wang Q, Li D, Wei X, Jia Y, Zhang Z, Ai B, Cao X, Guo T, Liao Y. Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer. J Exp Clin Cancer Res 2019;38:129. [PMID: 30876460 DOI: 10.1186/s13046-019-1120-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
35 Nomair AM, Madkour MA, Shamseya MM, Elsheredy HG, Shokr A. Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma. Clin Exp Hepatol 2019;5:317-26. [PMID: 31893244 DOI: 10.5114/ceh.2019.89478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Bel'skaya LV, Sarf EA, Kosenok VK. Analysis of Saliva Lipids in Breast and Prostate Cancer by IR Spectroscopy. Diagnostics (Basel) 2021;11:1325. [PMID: 34441260 DOI: 10.3390/diagnostics11081325] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Gomez-Casati DF, Zanor MI, Busi MV. Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases. Biomed Res Int 2013;2013:792527. [PMID: 23986911 DOI: 10.1155/2013/792527] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
38 Ishikawa M, Saito K, Yamada H, Nakatsu N, Maekawa K, Saito Y. Plasma lipid profiling of different types of hepatic fibrosis induced by carbon tetrachloride and lomustine in rats. Lipids Health Dis 2016;15:74. [PMID: 27068811 DOI: 10.1186/s12944-016-0244-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
39 Liang Q, Liu H, Wang C, Li B. Phenotypic Characterization Analysis of Human Hepatocarcinoma by Urine Metabolomics Approach. Sci Rep. 2016;6:19763. [PMID: 26805550 DOI: 10.1038/srep19763] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
40 Ali A, Levantini E, Teo JT, Goggi J, Clohessy JG, Wu CS, Chen L, Yang H, Krishnan I, Kocher O, Zhang J, Soo RA, Bhakoo K, Chin TM, Tenen DG. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer. EMBO Mol Med 2018;10:e8313. [PMID: 29449326 DOI: 10.15252/emmm.201708313] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
41 Skill NJ, Elliott CM, Ceballos B, Saxena R, Pepin R, Bettcher L, Ellensberg M, Raftery D, Malucio MA, Ekser B, Mangus RS, Kubal CA. Metabolomic Characterization of Human Model of Liver Rejection Identifies Aberrancies Linked to Cyclooxygenase (COX) and Nitric Oxide Synthase (NOS). Ann Transplant 2019;24:341-9. [PMID: 31182705 DOI: 10.12659/AOT.913800] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
42 Xiao J, Zhao Y, Varghese RS, Zhou B, Di Poto C, Zhang L, Tadesse MG, Ziada DH, Shetty K, Ressom HW. Evaluation of metabolite biomarkers for hepatocellular carcinoma through stratified analysis by gender, race, and alcoholic cirrhosis. Cancer Epidemiol Biomarkers Prev 2014;23:64-72. [PMID: 24186894 DOI: 10.1158/1055-9965.EPI-13-0327] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
43 Wu T, Zheng X, Yang M, Zhao A, Li M, Chen T, Panee J, Jia W, Ji G. Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients. Sci Rep 2017;7:42710. [PMID: 28198443 DOI: 10.1038/srep42710] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
44 Fang ZZ, Gonzalez FJ. LC-MS-based metabolomics: an update. Arch Toxicol 2014;88:1491-502. [PMID: 24710571 DOI: 10.1007/s00204-014-1234-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
45 Tang X, Brindley DN. Lipid Phosphate Phosphatases and Cancer. Biomolecules 2020;10:E1263. [PMID: 32887262 DOI: 10.3390/biom10091263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
46 Ng SSW, Jang GH, Kurland IJ, Qiu Y, Guha C, Dawson LA. Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy. EBioMedicine. 2020;59:102973. [PMID: 32891936 DOI: 10.1016/j.ebiom.2020.102973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
47 Haberl EM, Pohl R, Rein-Fischboeck L, Höring M, Krautbauer S, Liebisch G, Buechler C. Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease. Lipids Health Dis 2020;19:250. [PMID: 33298075 DOI: 10.1186/s12944-020-01425-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Khalil A, Elfert A, Ghanem S, Helal M, Abdelsattar S, Elgedawy G, Obada M, Abdel-samiee M, El-said H. The role of metabolomics in hepatocellular carcinoma. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00085-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Saito K, Ueta M, Maekawa K, Sotozono C, Kinoshita S, Saito Y. Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. PLoS One 2016;11:e0167402. [PMID: 27898730 DOI: 10.1371/journal.pone.0167402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Liesenfeld DB, Habermann N, Owen RW, Scalbert A, Ulrich CM. Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiol Biomarkers Prev 2013;22:2182-201. [PMID: 24096148 DOI: 10.1158/1055-9965.EPI-13-0584] [Cited by in Crossref: 87] [Cited by in F6Publishing: 49] [Article Influence: 9.7] [Reference Citation Analysis]
51 Nam M, Seo SS, Jung S, Jang SY, Lee J, Kwon M, Khan I, Ryu DH, Kim MK, Hwang GS. Comparable Plasma Lipid Changes in Patients with High-Grade Cervical Intraepithelial Neoplasia and Patients with Cervical Cancer. J Proteome Res 2021;20:740-50. [PMID: 33241689 DOI: 10.1021/acs.jproteome.0c00640] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Telu KH, Yan X, Wallace WE, Stein SE, Simón-Manso Y. Analysis of human plasma metabolites across different liquid chromatography/mass spectrometry platforms: Cross-platform transferable chemical signatures. Rapid Commun Mass Spectrom 2016;30:581-93. [PMID: 26842580 DOI: 10.1002/rcm.7475] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
53 Zhang QQ, Huang WQ, Gao YQ, Han ZD, Zhang W, Zhang ZJ, Xu FG. Metabolomics Reveals the Efficacy of Caspase Inhibition for Saikosaponin D-Induced Hepatotoxicity. Front Pharmacol 2018;9:732. [PMID: 30034340 DOI: 10.3389/fphar.2018.00732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Nezami Ranjbar MR, Luo Y, Di Poto C, Varghese RS, Ferrarini A, Zhang C, Sarhan NI, Soliman H, Tadesse MG, Ziada DH, Roy R, Ressom HW. GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort. PLoS One 2015;10:e0127299. [PMID: 26030804 DOI: 10.1371/journal.pone.0127299] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
55 Wang L, Wang Z, Xing Y, Liu E, Gao X, Wang L, Fu Z. Biomarkers and Mechanism Analysis for Polygoni Multiflori Radix Preparata-Induced Liver Injury by UHPLC-Q-TOF-MS-Based Metabolomics. Evid Based Complement Alternat Med 2021;2021:7677392. [PMID: 34858511 DOI: 10.1155/2021/7677392] [Reference Citation Analysis]
56 Fahrner R, Dondorf F, Ardelt M, Dittmar Y, Settmacher U, Rauchfuß F. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival. World J Gastroenterol 2015; 21(42): 12071-12082 [PMID: 26576092 DOI: 10.3748/wjg.v21.i42.12071] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
57 Beyoğlu D, Idle JR. The metabolomic window into hepatobiliary disease. J Hepatol 2013;59:842-58. [PMID: 23714158 DOI: 10.1016/j.jhep.2013.05.030] [Cited by in Crossref: 125] [Cited by in F6Publishing: 122] [Article Influence: 13.9] [Reference Citation Analysis]
58 Li F, Zhu W, Gonzalez FJ. Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol Ther 2017;178:18-30. [PMID: 28322972 DOI: 10.1016/j.pharmthera.2017.03.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
59 Lu Y, Chen J, Huang C, Li N, Zou L, Chia SE, Chen S, Yu K, Ling Q, Cheng Q, Zhu M, Zhang W, Chen M, Ong CN. Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers. Oncotarget 2018;9:5032-43. [PMID: 29435160 DOI: 10.18632/oncotarget.23494] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
60 Jeong DW, Lee S, Chun YS. How cancer cells remodel lipid metabolism: strategies targeting transcription factors. Lipids Health Dis 2021;20:163. [PMID: 34775964 DOI: 10.1186/s12944-021-01593-8] [Reference Citation Analysis]
61 Teng CF, Wu HC, Hsieh WC, Tsai HW, Su IJ. Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis. J Virol 2015;89:605-14. [PMID: 25339766 DOI: 10.1128/JVI.02363-14] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
62 Liu SY, Zhang RL, Kang H, Fan ZJ, Du Z. Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2013; 19(22): 3423-3432 [PMID: 23801834 DOI: 10.3748/wjg.v19.i22.3423] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
63 Yang S, Wang Z, Guo M, Du M, Wen X, Geng L, Yu F, Liu L, Li Y, Feng L, Zhou T. UPLC-MS-Based Serum Metabolomics Reveals Potential Biomarkers of Ang II-Induced Hypertension in Mice. Front Cardiovasc Med 2021;8:683859. [PMID: 34026879 DOI: 10.3389/fcvm.2021.683859] [Reference Citation Analysis]
64 Muir K, Hazim A, He Y, Peyressatre M, Kim DY, Song X, Beretta L. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res 2013;73:4722-31. [PMID: 23749645 DOI: 10.1158/0008-5472.CAN-12-3797] [Cited by in Crossref: 89] [Cited by in F6Publishing: 60] [Article Influence: 9.9] [Reference Citation Analysis]
65 Wulaningsih W, Garmo H, Holmberg L, Hammar N, Jungner I, Walldius G, Van Hemelrijck M. Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study. J Cancer Epidemiol. 2012;2012:792034. [PMID: 22969802 DOI: 10.1155/2012/792034] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
66 Liu G, Hou G, Li L, Li Y, Zhou W, Liu L. Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo. Oncotarget 2016;7:32607-16. [PMID: 27119355 DOI: 10.18632/oncotarget.8927] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
67 Lee S, Mardinoglu A, Zhang C, Lee D, Nielsen J. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis. Nucleic Acids Res. 2016;44:5529-5539. [PMID: 27216817 DOI: 10.1093/nar/gkw462] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
68 Sangineto M, Villani R, Cavallone F, Romano A, Loizzi D, Serviddio G. Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma.Cancers (Basel). 2020;12. [PMID: 32486341 DOI: 10.3390/cancers12061419] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
69 Getnet D, Gautam A, Kumar R, Hoke A, Cheema AK, Rossetti F, Schultz CR, Hammamieh R, Lumley LA, Jett M. Poisoning with Soman, an Organophosphorus Nerve Agent, Alters Fecal Bacterial Biota and Urine Metabolites: a Case for Novel Signatures for Asymptomatic Nerve Agent Exposure. Appl Environ Microbiol 2018;84:e00978-18. [PMID: 30217846 DOI: 10.1128/AEM.00978-18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Pazienza V, Vinciguerra M, Mazzoccoli G. PPARs Signaling and Cancer in the Gastrointestinal System. PPAR Res. 2012;2012:560846. [PMID: 23028383 DOI: 10.1155/2012/560846] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
71 Clarke JD, Novak P, Lake AD, Shipkova P, Aranibar N, Robertson D, Severson PL, Reily MD, Futscher BW, Lehman-McKeeman LD, Cherrington NJ. Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease. Dig Dis Sci. 2014;59:365-374. [PMID: 24048683 DOI: 10.1007/s10620-013-2873-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
72 Nishikawa T, Bellance N, Damm A, Bing H, Zhu Z, Handa K, Yovchev MI, Sehgal V, Moss TJ, Oertel M. A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. J Hepatol. 2014;60:1203-1211. [PMID: 24583248 DOI: 10.1016/j.jhep.2014.02.014] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
73 Ismail IT, Fiehn O, Elfert A, Helal M, Salama I, El-Said H. Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver Tissues. Cancers (Basel) 2020;12:E484. [PMID: 32092943 DOI: 10.3390/cancers12020484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
74 Teng CF, Wu HC, Shyu WC, Jeng LB, Su IJ. Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cell Transplant 2017;26:429-38. [PMID: 28195035 DOI: 10.3727/096368916X694382] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
75 Koeberle A, Shindou H, Koeberle SC, Laufer SA, Shimizu T, Werz O. Arachidonoyl-phosphatidylcholine oscillates during the cell cycle and counteracts proliferation by suppressing Akt membrane binding. Proc Natl Acad Sci USA. 2013;110:2546-2551. [PMID: 23359699 DOI: 10.1073/pnas.1216182110] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 6.2] [Reference Citation Analysis]
76 Zhou CX, Gan Y, Elsheikha HM, Chen XQ, Cong H, Liu Q, Zhu XQ. Sulfadiazine Sodium Ameliorates the Metabolomic Perturbation in Mice Infected with Toxoplasma gondii. Antimicrob Agents Chemother 2019;63:e00312-19. [PMID: 31383652 DOI: 10.1128/AAC.00312-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
77 Guo W, Tan HY, Wang N, Wang X, Feng Y. Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation. Cancer Manag Res 2018;10:715-34. [PMID: 29692630 DOI: 10.2147/CMAR.S156837] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
78 Jiao J, Kwan SY, Sabotta CM, Tanaka H, Veillon L, Warmoes MO, Lorenzi PL, Wang Y, Wei P, Hawk ET, Almeda JL, McCormick JB, Fisher-Hoch SP, Beretta L. Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics. Cancer Epidemiol Biomarkers Prev 2021;30:1643-51. [PMID: 34155064 DOI: 10.1158/1055-9965.EPI-21-0183] [Reference Citation Analysis]
79 Fitian AI, Nelson DR, Liu C, Xu Y, Ararat M, Cabrera R. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS. Liver Int 2014;34:1428-44. [PMID: 24661807 DOI: 10.1111/liv.12541] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.9] [Reference Citation Analysis]
80 Beyoğlu D, Imbeaud S, Maurhofer O, Bioulac-Sage P, Zucman-Rossi J, Dufour JF, Idle JR. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification. Hepatology 2013;58:229-38. [PMID: 23463346 DOI: 10.1002/hep.26350] [Cited by in Crossref: 122] [Cited by in F6Publishing: 127] [Article Influence: 13.6] [Reference Citation Analysis]
81 Pabst T, Kortz L, Fiedler GM, Ceglarek U, Idle JR, Beyoğlu D. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features. BBA Clin 2017;7:105-14. [PMID: 28331812 DOI: 10.1016/j.bbacli.2017.03.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
82 Zhao T, Fang F, Wang H, Lv C, Han M, Zhang Z, Wang F, Li B, Ling C. Effect of Aerobic Exercise on Serum Metabolites in Mice with Hepatocellular Carcinoma After Surgery. Med Sci Monit 2019;25:3181-9. [PMID: 31038126 DOI: 10.12659/MSM.913377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Cui X, Yang Q, Li B, Tang J, Zhang X, Li S, Li F, Hu J, Lou Y, Qiu Y, Xue W, Zhu F. Assessing the Effectiveness of Direct Data Merging Strategy in Long-Term and Large-Scale Pharmacometabonomics. Front Pharmacol 2019;10:127. [PMID: 30842738 DOI: 10.3389/fphar.2019.00127] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
84 Pan HY, Wu QQ, Yin QQ, Dai YN, Huang YC, Zheng W, Hui TC, Chen MJ, Wang MS, Zhang JJ, Huang HJ, Tong YX. LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis. ACS Omega 2021;6:1160-70. [PMID: 33490775 DOI: 10.1021/acsomega.0c04259] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Tripp BA, Dillon ST, Yuan M, Asara JM, Vasunilashorn SM, Fong TG, Metzger ED, Inouye SK, Xie Z, Ngo LH, Marcantonio ER, Libermann TA, Otu HH. Targeted metabolomics analysis of postoperative delirium. Sci Rep 2021;11:1521. [PMID: 33452279 DOI: 10.1038/s41598-020-80412-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Paul B, Lewinska M, Andersen JB. Lipid alterations in chronic liver disease and liver cancer. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100479] [Reference Citation Analysis]
87 Wei S, Suryani Y, Gowda GA, Skill N, Maluccio M, Raftery D. Differentiating hepatocellular carcinoma from hepatitis C using metabolite profiling. Metabolites. 2012;2:701-716. [PMID: 24957758 DOI: 10.3390/metabo2040701] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
88 Piszcz J, Armitage EG, Ferrarini A, Rupérez FJ, Kulczynska A, Bolkun L, Kloczko J, Kretowski A, Urbanowicz A, Ciborowski M, Barbas C. To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients. Oncotarget 2016;7:22324-38. [PMID: 26988915 DOI: 10.18632/oncotarget.8078] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
89 Xu QY, Liu YH, Zhang Q, Ma B, Yang ZD, Liu L, Yao D, Cui GB, Sun JJ, Wu ZM. Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats. Acta Pharmacol Sin 2014;35:1265-73. [PMID: 25220639 DOI: 10.1038/aps.2014.72] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
90 Saito K, Kagawa T, Tsuji K, Kumagai Y, Sato K, Sakisaka S, Sakamoto N, Aiso M, Hirose S, Mori N, Tanaka R, Uraoka T, Takata K, Ogawa K, Mori K, Sato M, Nishiya T, Takamatsu K, Arakawa N, Izumi T, Ohno Y, Saito Y, Takikawa H. Plasma Lipid Profiling of Three Types of Drug-Induced Liver Injury in Japanese Patients: A Preliminary Study. Metabolites 2020;10:E355. [PMID: 32878279 DOI: 10.3390/metabo10090355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
91 Aragonès G, Auguet T, Berlanga A, Guiu-Jurado E, Martinez S, Armengol S, Sabench F, Ras R, Hernandez M, Aguilar C, Colom J, Sirvent JJ, Del Castillo D, Richart C. Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. PLoS One 2016;11:e0154601. [PMID: 27123846 DOI: 10.1371/journal.pone.0154601] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
92 Ioannou GN, Nagana Gowda GA, Djukovic D, Raftery D. Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach. Metabolites 2020;10:E168. [PMID: 32344559 DOI: 10.3390/metabo10040168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
93 Fitian AI, Cabrera R. Disease monitoring of hepatocellular carcinoma through metabolomics. World J Hepatol 2017; 9(1): 1-17 [PMID: 28105254 DOI: 10.4254/wjh.v9.i1.1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
94 Zhan X, Patterson AD, Ghosh D. Kernel approaches for differential expression analysis of mass spectrometry-based metabolomics data. BMC Bioinformatics 2015;16:77. [PMID: 25887233 DOI: 10.1186/s12859-015-0506-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
95 Jin Y, Ren Z, Tan Y, Zhao P, Wu J. Motility Plays an Important Role in the Lifetime of Mammalian Lipid Droplets. Int J Mol Sci 2021;22:3802. [PMID: 33916886 DOI: 10.3390/ijms22083802] [Reference Citation Analysis]
96 Cotte AK, Cottet V, Aires V, Mouillot T, Rizk M, Vinault S, Binquet C, de Barros JP, Hillon P, Delmas D. Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients. Oncotarget 2019;10:2161-72. [PMID: 31040908 DOI: 10.18632/oncotarget.26738] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
97 Chen Y, Song X, Valanejad L, Vasilenko A, More V, Qiu X, Chen W, Lai Y, Slitt A, Stoner M. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma. Hepatology. 2013;57:1530-1541. [PMID: 23213087 DOI: 10.1002/hep.26187] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
98 Khan IM, Gjuka D, Jiao J, Song X, Wang Y, Wang J, Wei P, El-Serag HB, Marrero JA, Beretta L. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila) 2021;14:667-74. [PMID: 33685927 DOI: 10.1158/1940-6207.CAPR-20-0600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Sánchez-Rodríguez P, Rodríguez MC, Sánchez-Yagüe J. Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer. Tumour Biol 2015;36:5687-98. [PMID: 25702090 DOI: 10.1007/s13277-015-3243-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
100 Khalil A, Elsheashaey A, Abdelsameea E, Obada M, Bayomy F.f. M, El-said H. Value of Bile Acids in Diagnosing Hepatitis C Virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma. Br J Biomed Sci 2022;79:10191. [DOI: 10.3389/bjbs.2021.10191] [Reference Citation Analysis]
101 Daldrup-Link H. Artificial intelligence applications for pediatric oncology imaging. Pediatr Radiol 2019;49:1384-90. [PMID: 31620840 DOI: 10.1007/s00247-019-04360-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
102 Khalid A, Siddiqui AJ, Huang JH, Shamsi T, Musharraf SG. Alteration of Serum Free Fatty Acids are Indicators for Progression of Pre-leukaemia Diseases to Leukaemia. Sci Rep 2018;8:14883. [PMID: 30291286 DOI: 10.1038/s41598-018-33224-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
103 Xu S, Chen Y, Ma Y, Liu T, Zhao M, Wang Z, Zhao L. Lipidomic Profiling Reveals Disruption of Lipid Metabolism in Valproic Acid-Induced Hepatotoxicity. Front Pharmacol 2019;10:819. [PMID: 31379584 DOI: 10.3389/fphar.2019.00819] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
104 Kim S, Rhee JK, Yoo HJ, Lee HJ, Lee EJ, Lee JW, Yu JH, Son BH, Gong G, Kim SB, Singh SR, Ahn SH, Chang S. Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer. Cancer Lett 2015;357:488-97. [PMID: 25484137 DOI: 10.1016/j.canlet.2014.11.058] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
105 Khan A, Alhumaydhi FA, Alwashmi ASS, Allemailem KS, Alsahli MA, Alrumaihi FA, Almatroudi A, Mobark MA, Mousa A, Khan MA. Diallyl Sulfide-Mediated Modulation of the Fatty Acid Synthase (FASN) Leads to Cancer Cell Death in BaP-Induced Lung Carcinogenesis in Swiss Mice. J Inflamm Res 2020;13:1075-87. [PMID: 33324084 DOI: 10.2147/JIR.S284279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
106 Yao G, Yin J, Wang Q, Dong R, Lu J. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells. Biomed Res Int 2019;2019:2560650. [PMID: 31781603 DOI: 10.1155/2019/2560650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
107 Mocan T, Kang DW, Molloy BJ, Jeon H, Spârchez ZA, Beyoğlu D, Idle JR. Plasma fetal bile acids 7α-hydroxy-3-oxochol-4-en-24-oic acid and 3-oxachola-4,6-dien-24-oic acid indicate severity of liver cirrhosis. Sci Rep 2021;11:8298. [PMID: 33859329 DOI: 10.1038/s41598-021-87921-5] [Reference Citation Analysis]
108 Kim JU, Shariff MIF, Crossey MME, Gomez-Romero M, Holmes E, Cox IJ, Fye HKS, Njie R, Taylor-Robinson SD. Hepatocellular carcinoma: Review of disease and tumor biomarkers. World J Hepatol 2016; 8(10): 471-484 [PMID: 27057305 DOI: 10.4254/wjh.v8.i10.471] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]